Resize Text:
Toll Free: 1.888.9EXALGO (1.888.939.2546) Fax: 1.888.423.3511


       Please set browser to allow popups for online submission feature.


EXALGO Call Center

Phone: 1.888.9EXALGO (1.888.939.2546)

Fax: 1.888.423.3511

Please report all suspected adverse events associated with the use of EXALGO to Covidien Product Monitoring at 1.800.778.7898.

Adverse event information may also be reported to the FDA MedWatch Reporting System by phone at 1.800.FDA.1088 (1.800.332.1088) or by mail using Form 3500 at www.fda.gov/medwatch.

If you have any questions or concerns, you may contact our Product Monitoring department at 1.800.778.7898.


Contact Us (*indicates a required field)               

First Name*

Last Name*

Health Care Specialty

Address

City

State

Zip

Telephone* (xxx-xxx-xxxx)

Fax

Email Address*

I am interested in the following:


                                                                              Submit code
Enter the code shown above:

Please see full prescribing information including BOXED WARNING.
PHYSICIANS AND OTHER HEALTHCARE PROVIDERS MUST BECOME FAMILIAR WITH THE IMPORTANT WARNINGS IN THIS LABEL.

WARNING: POTENTIAL FOR ABUSE, IMPORTANCE OF
PROPER PATIENT SELECTION AND LIMITATIONS OF USE

Potential for Abuse

EXALGO contains hydromorphone, an opioid agonist and a Schedule II controlled substance with an abuse liability similar to other opioid analgesics. EXALGO can be abused in a manner similar to other opioid agonists, legal or illicit. These risks should be considered when administering, prescribing, or dispensing EXALGO in situations where the healthcare professional is concerned about increased risk of misuse, abuse, or diversion. Schedule II opioid substances which include hydromorphone, morphine, oxycodone, fentanyl, oxymorphone and methadone have the highest potential for abuse and risk of fatal overdose due to respiratory depression.

Proper Patient Selection

EXALGO is an extended release formulation of hydromorphone hydrochloride indicated for the management of moderate to severe pain in opioid tolerant patients when a continuous around-the-clock opioid analgesic is needed for an extended period of time. Patients considered opioid tolerant are those who are taking at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl/hour, 30 mg of oral oxycodone/day, 8 mg oral hydromorphone/day, 25 mg of oral oxymorphone/day or an equianalgesic dose of another opioid, for a week or longer.
EXALGO is for use in opioid tolerant patients only.
Fatal respiratory depression could occur in patients who are not opioid tolerant.
Accidental consumption of EXALGO, especially in children, can result in a fatal overdose of hydromorphone.

Limitations of Use

EXALGO is not indicated for the management of acute or postoperative pain.
EXALGO is not intended for use as an as needed analgesic.
EXALGO tablets are to be swallowed whole and are not to be broken, chewed, dissolved, crushed or injected. Taking broken, chewed, dissolved or crushed EXALGO or its contents leads to rapid release and absorption of a potentially fatal dose of hydromorphone.